Search Results 231-240 of 16999 for hla genotype

  1. Publications - Aaron J. Wyse, M.D. - Mayo Clinic

    Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution. Nat Genet. 2023 Dec; 55 (12):2255-2268 Epub 2023 Nov 30. View ...

  2. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

    About this study. This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single ...

  3. Neurosciences Clinical Trials - Medical Professionals

    ... genotype, including understudied APOE2 and APOE4 homozygotes (HMs) at the lowest and highest risk and those APOE4 HMs and heterozygotes (HTs) who remain ...

  4. Publications - Lois E. Krahn, M.D. - Mayo Clinic

    Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Biol Psychiatry. 2005 Sep 15; ...

  5. A Study Of Severe Combined Immunodeficiency Disorders - Mayo Clinic

    ... HLA by flow/serology. For Omenn Syndrome. Generalized skin rash; Maternal lymphocytes not detected; Absent or low (< 30% lower limit of normal) T cell ...

  6. Clinical Services - Todd and Karen Wanek Family Program for HLHS - Mayo Clinic Research

    Todd and Karen Wanek Family Program for HLHS at Mayo Clinic: Clinical cardiology services for patients with hypoplastic left heart syndrome.

  7. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate, goserelin acetate, ...

  8. https://www.mayoclinic.org/chinese_organization_concepts.xml

  9. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients who are human leukocyte antigen (HLA)-A2 positive. 7. Patients should have radiologically measurable disease with a lymph node or tumor mass ...

  10. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC - Mayo Clinic

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...